SARAH CHAPMAN: Open Payments
NPI 1851880777 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 19 payments from 10 companies in 2025. Trend: 2023 $656 · 2024 $348 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $55 |
| Exeltis, USA Inc. | 3 | $46 |
| Exact Sciences Corporation | 3 | $43 |
| Dexcom, Inc. | 2 | $42 |
| Biogen, Inc. | 2 | $33 |
| MILLICENT US INC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Organon LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, SLYND, Cologuard Collection Kit, Dexcom G6 Transmitter, ZURZUVAE, FEMLYV, MYFEMBREE, ABRYSVO.
Industry payments across IN — which companies pay providers there.
